KEROS THERAPEUTICS INC. - COMMON STOCK

Keros Therapeutics Reports Recent Business Highlights and First Quarter 2021 Financial Results

06 مايو 2021 13:01:02 بحسب Nasdaq GlobeNewswire

Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2020 Financial Results

25 مارس 2021 05:00:01 بحسب Nasdaq GlobeNewswire

Keros Therapeutics Presents Results from Preclinical Studies of KER-050 and ALK2 Inhibitors at the European School of Haematology (ESH) 2nd Translational Research E-Conference

05 مارس 2021 05:00:00 بحسب Nasdaq GlobeNewswire

Keros Therapeutics to Present at the H.C. Wainwright Global Life Sciences 2021 Virtual Conference

02 مارس 2021 05:00:02 بحسب Nasdaq GlobeNewswire

Keros Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference

17 فبراير 2021 05:00:01 بحسب Nasdaq GlobeNewswire